Clinical trial
Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary…
NCT00148356 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00148356 |
|---|---|
| Title | Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries |
| Official title | A Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the ZoMaxx Drug Eluting Coronary Stent System Compared to the TAXUS™ Express2 Paclitaxel-Eluting Coronary Stent System in de Novo Coronary Artery Lesions |
| Acronym | ZoMaxx™ I |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Disease, Coronary Artery Disease, Coronary Restenosis |
| Intervention type | Device |
| Interventions | ZoMaxx™ Drug-Eluting Coronary Stent System, TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent System |
| Enrollment | 401 |
| Start date | Sep 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | Oct 1, 2010 |
| First posted | Sep 8, 2005 |
| Last update posted | Apr 1, 2011 |
| Countries | Australia, Belgium, Denmark, France, Germany, Netherlands, New Zealand, Portugal, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: